Modulatory crosstalks of innate lymphoid cells and natural killer cells in T cell-driven glioma Immunotherapies
Enhancing CAR T cell infiltration into solid tumors via metabolite accumulation mediated migration
Characterization of the fusion-epitope specific TCR repertoire in patients with liposarcoma
Medienkontakt:
Bristol Myers Squibb-Stiftung Immunonkologie
Claudia Neumann c/o Bristol Myers Squibb GmbH & Co. KGaA
Arnulfstraße 29, 80636 München
T: 089 – 121 42 433
E: viola.elsner@stiftung-io.org
Hauptmenü
Förderbereiche
Rechtliches
©2023 Bristol Myers Squibb - Stiftung Immunonkologie
Telefon: 089 – 121 42 433
E-Mail: info@stiftung-io.org